MicroRNA signature predicts survival and relapse in lung cancer

被引：728

作者：

Yu, Sung-Liang ^{[1
,2
,5
]}

Chen, Hsuan-Yu ^{[1
,6
]}

Chang, Gee-Chen ^{[9
,11
]}

Chen, Chih-Yi ^{[7
,10
,12
]}

Chen, Huei-Wen ^{[13
]}

Singh, Sher ^{[14
]}

Cheng, Chiou-Ling ^{[1
]}

Yu, Chong-Jen ^{[4
]}

Lee, Yung-Chie ^{[3
]}

Chen, Han-Shiang ^{[15
,16
]}

Su, Te-Jen ^{[1
,11
]}

Chiang, Ching-Cheng ^{[1
]}

Li, Han-Ni ^{[1
]}

Hong, Qi-Sheng ^{[1
]}

Su, Hsin-Yuan ^{[1
]}

Chen, Chun-Chieh ^{[1
]}

Chen, Wan-Jiun ^{[13
]}

Liu, Chun-Chi ^{[11
]}

Chan, Wing-Kai ^{[5
]}

Chen, Wei J. ^{[1
,6
]}

Li, Ker-Chau ^{[7
,17
]}

Chen, Jeremy J. W. ^{[1
,11
]}

Yang, Pan-Chyr ^{[1
,4
,8
]}

机构：

[1] Natl Taiwan Univ, Coll Med, NTU Ctr Genem Med, Taipei 100, Taiwan

[2] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan

[3] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan

[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan

[5] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan

[6] Natl Taiwan Univ, Coll Med, Grad Inst Epidemiol, Taipei 100, Taiwan

[7] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan

[8] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan

[9] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung 407, Taiwan

[10] Taichung Vet Gen Hosp, Div Thorac Surg, Dept Surg, Taichung 407, Taiwan

[11] Natl Chung Hsing Univ, Inst Biomed Sci & Mol Biol, Taichung 402, Taiwan

[12] China Med Univ Hosp, Sch Med, Dept Surg, Div Thorac Surg, Taichung 404, Taiwan

[13] Natl Yang Ming Univ, Coll Med, Inst Pharmacol, Taipei 112, Taiwan

[14] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 116, Taiwan

[15] Hualien Tzu Chi Med Ctr, Dept Colon & Rectal Surg, Hualien 970, Taiwan

[16] Hualien Tzu Chi Med Ctr, Dept Surg, Hualien 970, Taiwan

[17] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA

来源：

CANCER CELL | 2008年 / 13卷 / 01期

基金：

美国国家科学基金会;

关键词：

D O I：

10.1016/j.ccr.2007.12.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We investigated whether microRNA expression profiles can predict clinical outcome of NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 NSCLC patients, which were divided into the training and testing sets. Using Cox regression and risk-score analysis, we identified a five-microRNA signature for the prediction of treatment outcome of NSCLC in the training set. This microRNA signature was validated by the testing set and an independent cohort. Patients with high-risk scores in their microRNA signatures had poor overall and disease-free survivals compared to the low-risk-score patients. This microRNA signature is an independent predictor of the cancer relapse and survival of NSCLC patients.

引用

页码：48 / 57

页数：10

共 46 条

[31] Biomarkers in cancer staging, prognosis and treatment selection
Ludwig, JA
Weinstein, JN
[J]. NATURE REVIEWS CANCER, 2005, 5 (11) : 845 - 856
[32] Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation
Mayr, Christine
Hemann, Michael T.
Bartel, David P.
[J]. SCIENCE, 2007, 315 (5818) : 1576 - 1579
[33] Pathogenesis of lung cancer - 100 year report
Miller, YE
[J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (03) : 216 - 223
[34] DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Olaussen, Ken A.
Dunant, Ariane
Fouret, Pierre
Brambilla, Elisabeth
Andre, Fabrice
Haddad, Vincent
Taranchon, Estelle
Filipits, Martin
Pirker, Robert
Popper, Helmut H.
Stahel, Rolf
Sabatier, Laure
Pignon, Jean-Pierre
Tursz, Thomas
Le Chevalier, Thierry
Soria, Jean-Charles
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) : 983 - 991
[35] MicroRNAs modulate the angiogenic properties of HLTVECs
Poliseno, Laura
Tuccoli, Andrea
Mariani, Laura
Evangelista, Monica
Citti, Lorenzo
Woods, Keith
Mercatanti, Alberto
Hammond, Scott
Rainaldi, Giuseppe
[J]. BLOOD, 2006, 108 (09) : 3068 - 3071
[36] RETRACTED: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007)
Potti, Anil
Mukherjee, Sayan
Petersen, Rebecca
Dressman, Holly K.
Bild, Andrea
Koontz, Jason
Kratzke, Robert
Watson, Mark A.
Kelley, Michael
Ginsburg, Geoffrey S.
West, Mike
Harpole, David H., Jr.
Nevins, Joseph R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) : 570 - 580
[37] Translating cancer genomics into clinical oncology
Ramaswamy, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) : 1814 - 1816
[38] MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Roldo, Claudia
Missiaglia, Edoardo
Hagan, John P.
Falconi, Massimo
Capelli, Paola
Bersani, Samantha
Calin, George Adrian
Volinia, Stefano
Liu, Chang-Gong
Scarpa, Aldo
Croce, Carlo M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4677 - 4684
[39] Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
Seymour, Matthew T.
Maughan, Timothy S.
Ledermann, Jonathan A.
Topham, Clare
James, Roger
Gwyther, Stephen J.
Smith, David B.
Shepherd, Stephen
Maraveyas, Anthony
Ferry, David R.
Meade, Angela M.
Thompson, Lindsay
Griffiths, Gareth O.
Parmar, Mahesh K. B.
Stephens, Richard J.
[J]. LANCET, 2007, 370 (9582) : 143 - 152
[40] Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells
Shridhar, R
Zhang, J
Song, J
Booth, BA
Kevil, CG
Sotiropoulou, G
Fsloane, B
Keppler, D
[J]. ONCOGENE, 2004, 23 (12) : 2206 - 2215

← 1 2 3 4 5 →